Aflac Incorporated (AFL) is a major provider of supplemental health and life insurance products, with a market cap of $57.6 billion. Analysts expect AFL to announce a profit of $1.80 per share for the fiscal third quarter of 2025, down from $2.16 per share in the previous year. For the full year, EPS is predicted to be $6.91, with a projected rebound to $7.35 in fiscal 2026.

Despite a 6.3% decline in AFL stock over the past year, on October 14, shares rose 1.1% following a “Buy” rating reaffirmation by Bank of America Securities analyst Joshua Shanker, with a price target of $130. Analysts overall hold a “Hold” rating on AFL stock, with an average price target of $108.57, indicating a slight upside from current levels.

Read more at Yahoo Finance: What to Expect From Aflac’s Q3 2025 Earnings Report